Position in ABUS
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$144,000
-$36,000 QoQ
Shares Held
30,000
-25.0% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#105
of 175 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Premier Path Wealth Partners, LLC holds $2,006,754 across 6 Biotechnology names. ABUS ranks #5 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,751 | $869,774 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
12,000 | $424,680 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
507 | $316,134 | |
| 4 | MRNA |
Moderna, Inc.
|
3,231 | $226,266 | |
| 5 | ABUS |
Arbutus Biopharma Corp
This page
|
30,000 | $144,000 | |
| 6 | AVXL |
Anavex Life Sciences Corp.
|
10,000 | $25,900 |
All Filings in ABUS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $144,000 | 30,000 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $180,000 | 40,000 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $192,400 | 40,000 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $181,600 | 40,000 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $123,600 | 40,000 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $139,600 | 40,000 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $130,800 | 40,000 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $154,000 | 40,000 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $111,240 | 36,000 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $78,690 | 30,500 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $55,500 | 22,200 | Shares | Sole | 2024-01-12 | |
| No filing history on record for this holder in this stock. | ||||||